
Unseen Risks, Unlocked Value: Quantifying Regulatory and Reimbursement Barriers in MedTech Investment | LSI Europe '25
This Workshop took place at LSI Europe ‘25 Emerging Medtech Summit in London.
Industry experts from TSTILL Enterprises, RegNav, and PRIA Healthcare examine how to identify and quantify regulatory and reimbursement challenges that impact medtech investment decisions, revealing hidden opportunities for value creation.
This Workshop featured:
Timothy Still — Revival Healthcare, TSTILL Enterprises
James Pink — RegNav, James Pink Advisory
Tonya Dowd — PRIA Healthcare
Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits
Follow us on social:
LinkedIn: https://www.linkedin.com/company/life-science-intelligence/
Twitter: https://twitter.com/lsintelligence
Instagram: https://www.instagram.com/lifescienceintelligence/
Facebook: https://www.facebook.com/LifeScienceIntelligence/
Spotify: https://open.spotify.com/show/7LnmGOwBMmRHJeDXmv3KEI?si=a93200169a884c09
Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw
More episodes from "Conversations from LSI"



Don't miss an episode of “Conversations from LSI” and subscribe to it in the GetPodcast app.








